¶ Natural Compounds and Phytotherapy for Neurodegeneration
Natural Compounds And Phytotherapy For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Natural compounds derived from plants, herbs, and traditional medicines have shown promising neuroprotective properties in neurodegenerative disease research. Many compounds have anti-inflammatory, antioxidant, and anti-aggregation effects that may complement conventional therapies.
- Source: Grapes, berries, peanuts
- Mechanisms: SIRT1 activation, antioxidant, anti-inflammatory, AMPK activation
- Evidence: Preclinical models show reduced Aβ and improved cognition
- Clinical: Mixed results in AD trials
- Dose: 250-500mg daily studied
- Source: Turmeric (Curcuma longa)
- Mechanisms: Anti-inflammatory, antioxidant, anti-aggregation, metal chelation
- Evidence: Reduces plaques and tangles in models
- Challenge: Poor bioavailability (enhanced formulations in development)
- Dose: 1-3g daily studied
- Source: Green tea
- Mechanisms: Antioxidant, anti-aggregation (Aβ, α-syn), protease activation
- Evidence: Protective in PD models
- Clinical: Trials ongoing
- Dose: 250-500mg daily
- Source: Onions, apples, berries
- Mechanisms: Antioxidant, anti-inflammatory, autophagy enhancement
- Evidence: Neuroprotection in AD/PD models
- Dose: 100-500mg daily
- Source: Scutellaria baicalensis (Chinese skullcap)
- Mechanisms: Anti-aggregation (α-syn), antioxidant, anti-inflammatory
- Evidence: Strong preclinical data in PD
- Dose: 100-300mg daily
- Source: Strawberries, mangoes
- Mechanisms: Antioxidant, anti-inflammatory, autophagy, senolytic
- Evidence: Extends lifespan in models
- Dose: 100mg daily (human equivalent)
- Source: Traditional Ayurvedic herb
- Mechanisms: Antioxidant, acetylcholinesterase inhibition, memory enhancement
- Evidence: Human trials show cognitive benefits
- Dose: 300-450mg daily extract
¶ Withania Somnifera (Ashwagandha)
- Source: Traditional Ayurvedic herb
- Mechanisms: GABAergic, anti-stress, antioxidant, anti-inflammatory
- Evidence: May improve cognition in MCI
- Dose: 300-600mg daily
- Source: Coffee, tea
- Mechanisms: Adenosine receptor antagonism, antioxidant
- Evidence: Epidemiological data shows reduced PD risk
- Dose: 200-400mg daily (moderate)
- Source: Cocoa, chocolate
- Mechanisms: Neuroprotection, vasodilation
- Evidence: May improve cerebral blood flow
- Curcumin: Plaque reduction
- Resveratrol: Cognitive preservation
- EGCG: Amyloid modulation
- Combined formulations in development
- EGCG: α-syn aggregation inhibition
- Baicalein: Motor protection
- Caffeine: Risk reduction
- Quercetin: Dopaminergic protection
- Curcumin: Anti-inflammatory
- EGCG: Motor neuron protection
- Resveratrol: Mitochondrial function
- Resveratrol: SIRT1 activation
- EGCG: Mutant huntingtin clearance
- Curcumin: Aggregate reduction
- Many natural compounds have poor CNS penetration
- Liposomal and nanoparticle formulations in development
- Combination approaches to enhance absorption
- Prodrug strategies
¶ Standardization
- Extract standardization important
- Batch-to-batch variation
- Quality control considerations
- Interaction with conventional drugs
- Resveratrol: Mixed results in AD (some cognitive preservation)
- Curcumin: Limited efficacy in AD (bioavailability issues)
- EGCG: Ongoing in PD/MCI
- Bacopa: Cognitive benefits in MCI
- Multiple polyphenol combinations in AD
- EGCG in early PD
- Natural compound cocktails
¶ Safety and Interactions
- Low toxicity profiles
- Few serious adverse effects
- Anticoagulants (vitamin K compounds)
- CYP450 enzyme interactions
- MAO inhibitors (some compounds)
- Blood pressure effects
- Enhanced bioavailability formulations
- Combination therapy approaches
- Biomarker-driven selection
- Precision phytotherapy
- Standardized extracts
The study of Natural Compounds And Phytotherapy For Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [@PMID:24442013] - Resveratrol and neurodegeneration
- [@PMID:18403753] - Curcumin and Alzheimer's disease
- [@PMID:19276553] - EGCG in Parkinson's disease
- [@PMID:25835076] - Quercetin neuroprotection
- [@PMID:23553579] - Baicalein and alpha-synuclein
- [@PMID:26586155] - Fisetin as senolytic
- [@PMID:18694236] - Bacopa and cognition
- [@PMID:23811665] - Ashwagandha neuroscience